Monoclonal Abs neutralize preferentially GP-1 variants that lack specific glycans.
Rami Sommerstein,Flatz Lukas, M. Remy Melissa, Pauline Malinge,Giovanni Magistrelli,Fischer Nicolas,Sahin Mehmet,Andréas Bergthaler, Sébastien Igonet, ter Meulen Jan, Rigo Dorothée,Meda Paolo, Nadia Rabah, Bruno Coutard,Bowden Thomas A., Lambert Paul-Henri, Siegrist Claire-Anne, D. Pinschewer Daniel PLOS Pathogens（2015）
AI 理解论文
溯源树
样例
